INTRODUCTION
Quantitative real-time PCR (qPCR) is a powerful technique that precisely measures and monitors the amplification of a specific nucleic acid sequence in a DNA sample. This technique has been applied to the quantification of gene expression, pathogen load counts, and identification of genetic mutations (1) (2) (3) . qPCR methodology also offers a valuable means to track and quantitate cells after adoptive transfer in vivo (4) (5) (6) . qPCR assays for Y chromosomespecific genes have been reported in sex-mismatched adoptive transfer experiments (6, 7) ; however sex determination is not always practicable, and both male and female donors and recipients are desirable in many studies.
Gene transfers into mice were first achieved in the early 1980s, and transgenic mice have been used extensively to study gene function and regulation and to model human disease. Transgenic mice ubiquitously expressing the enhanced green fluorescent protein (EGFP) under the control of the chicken β β-actin β-actin β promoter were first generated by Okabe et al. in 1997 (8) , followed by additional strains with different promoters. The fluorescent nature of these cells facilitates visualization and tracking in cell transplantation experiments (6, (9) (10) (11) (12) (13) (14) . In contrast to other reporter genes, no additional substrate is required for EGFP detection. Unlike biochemical labeling with fluorescent dyes, the EGFP transgene is inherited by all daughter cells, and the fluorescence does not fade as cells proliferate. EGFP also offers a safer alternative to the use of radioactively labeled cells.
qPCR methodology has not been widely used to quantitate EGFP transgene-bearing cells in biodistribution studies. The design of a qPCR assay to detect the EGFP transgene was first described in 2002 (1), however, because this technique was used to study in vivo viral transduction and was published in a specialty journal, it did not reach a broad scientific audience. A general review article described genes that could be detected in tissue by qPCR after adoptive transfer (6) , but transgene analysis and computations were not fully described and tissue analysis was not presented. This method has been used successfully to evaluate fetal microchimerism in wild-type female mice bred with EGFP-transgenic males (4, 5) and critical calculations for quantification of EGFP transgene were well described in a feline viral infection model (2) . However, based on the low frequency with which these few methodology publications have been cited, and the paucity of published articles using qPCR to quantitate biolocalized cells, it appears that this important methodology has failed to reach most immunologists and cell biologists conducting adoptive transfer experiments.
Here we report a detailed description of qPCR for the specific, objective, and rapid quantitation of tissue-localized transplanted EGFP-transgenic cells in a syngeneic murine tumor model. We, and others, have observed the biolocalization of adoptively transferred EGFP-VEC (vascular endothelial cells) and endothelial progenitor cells (EPC) to tumors using fluorescent microscopy (11, 13, 15, 16) . Quantitation of localized cells by immunofluorescent microscopy is subjective, time-consuming, and often complicated by tissue autofluorescence. The EGFP qPCR methodology described in this article is readily transferable to other models to enable the quantitation of tissue-localized cells in adoptive transfer experiments of different cell types.
MATERIALS AND METHODS

Mice
Animal studies were approved by East Carolina University Animal Care and Use Committee. Two-to six-monthold wild-type C57BL/6J mice were (8) . Since homozygous Act-EGFP pups do not survive >4 weeks, hemizygous mice were obtained by breeding transgenic male mice with C57BL/6 females. C57BL/6-Tg(UBC-GFP)30Scha/J (Ubq-EGFP) mice were also used for transgene copy number determinations. All mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA).
See Online Protocol available at www.BioTechniques.com.
Isolation and Culture of Murine VEC
VEC were isolated from 2-to 5-day-old EGFP-transgenic mouse pups (5-30 per preparation) and maintained in culture for 2 to 3 weeks as described (17) , except VEC media contained 15 μg/mL Endothelial Cell Growth Supplement, 2 U/mL heparin, and 10 mM HEPES (all from Sigma Aldrich, St. Louis, MO, USA).
Metastatic Tumor Model and Intravenous EGFP-VEC Injection
Lewis lung adenocarcinoma (LLCaB) cells were derived from an LLC1 (CRL-1642; ATCC, Manassas, VA, USA) metastatic tumor and cultured as described (18) . The metastatic model was originally reported by Folkman (19) and modified by our laboratory (20) . Mice bearing lung and liver metastases were injected intravenously with 2 × 10 6 EGFP-VEC and euthanized 24 h later. Organs were flash frozen for transgene copy number determination or frozen in Tissue Tek-OCT (optimum cutting temperature) compound (Sakura Finetek, Torrance, CA, USA) for biolocalization studies. Strict measures were taken to avoid sample cross-contamination. Separate surgical instruments were used for each mouse.
The control groups in this study were: (i) healthy mice not injected with EGFP-VEC (n = 5); (ii) metastases-bearing mice not injected with EGFP-VEC (n = 4); and (iii) healthy mice injected with EGFP-VEC (n = 5). The tumor group comprised metastases-bearing animals injected with EGFP-VEC (n = 6).
Subcutaneous Tumor Model and Intratumor EGFP-VEC Injection
Mice were injected subcutaneously (s. 
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OCT. Alternating 10 μm sections were examined by fluorescence microscopy or extracted for DNA. One mouse was removed from further analysis as it could not be enumerated by microscopy due to high tissue autofluorescence.
Confocal Microscopy
Four sections per s.c. tumor were randomly selected and corresponding z-stacks containing 10 1-μm optical sections were generated (Model no. LSM510; Carl Zeiss Micro Imaging, Thornwood, NY, USA). Four 100 μm 2 areas per tumor, each containing an apparent fluorescent cell, were similarly analyzed. The average and maximum fluorescent intensities were measured.
Isolation of Genomic DNA from Tissue
Genomic DNA was extracted from murine liver and lung tissue sections by the Phenol-Chloroform method (21) with the following modifications: (i) thawed 10-50 μm tissue sections were rinsed with PBS (320 osm, pH 7); (ii) an additional 1-h incubation with RNase (0.025 mg/mL) was included after tissue digestion in lysis buffer; and (iii) an additional rinse with chloroform/ isoamyl alcohol was included after Genomic DNA extraction with phenolchloroform-isoamyl alcohol. DNA concentration was always determined with a fluorescence assay using SYBR-green dye (22) , which was more accurate than spectrophotometric determination (OD 260 ). Thus, we calculated that each molecule, or copy, of pEGFP-N3 has a mass of ∼5.1 attograms (ag), and 1 ng of pEGFP-N3 has approximately 1.95 × 10 8 copies of EGFP. The number EGFP. The number EGFP of plasmid copies per microliter was determined by dividing the concentration of plasmid by mass (m). A pEGFP-N3 plasmid standard curve was constructed in each assay, as described in Figure 1 . qPCR qPCR was conducted with 100 ng DNA in duplicate in a 25 μl reaction using the TaqMan PCR Universal Master Mix and the Applied Biosystems 7000 Real-Time System (both from Applied Biosystems, Foster City, CA, USA). Primer and probe sequences for EGFP were from Jackson Laboratories (personal communication) and manufactured by Applied Biosystems: forward primer 5′-ccacatgaagcagcaggactt-3′, reverse primer 5′-ggtgcgctcctggacgta-3′ and probe 5′-6FAM-ttcaagtccgccatgcccgaa-TAMRA-3′. The final concentration of EGFP primers was 400 nM each, and the probe was 150 nM. Gene Expression Assay Mm00607939_s1 (Applied Biosystems) was used for assaying β-actin β-actin β (endogenous control) in separate reactions. This proprietary assay resulted in a 115 bp product within exon 6, detected with a FAM/ MGB-labeled probe. All reactions were 50 cycles using standard ABI cycling conditions (initial 2 m at 50°C, 10 m at 95°C, and 50 cycles of 15 s denaturation at 95°C and 1 m annealing and extension at 60°C).
The number of EGFP transgene copies in 100 ng DNA (from EGFP-transgenic mice or from wild-type mice transplanted with cells from EGFP-transgenic mice) was calculated from their respective C T (cycle threshold) using the linear equation from the respective plasmid standard curve. EGFP copy number per Figure 1A .
Contamination Precautions and Monitoring
Separate laboratories were used for tissue harvest, DNA isolation, and DNA amplification. PCR reactions were prepared in a designated work station (Template Tamer; Qbiogene, Inc., Carlsbad, CA, USA). Pipets and consumables were regularly treated by UV irradiation. Work surfaces, equipment and surgical instruments were routinely cleaned with DNA Exitus Plus (Applichem, Cheshire, CT, USA), bleach-containing disinfectants and UV treatment. Routine wipe tests of work areas were conducted at least monthly to screen for DNA contamination, as generally described for the Unitray DNA Wipe Test (Pel-Freez Biologicals, Rogers, AZ, USA) used in clinical laboratories (www.invitrogen. com/content/sfs/manuals/PR016_ REV04.pdf). The elution from wiped areas was tested by qPCR for mouse β-actin β-actin β . Figure 1A outlines the overall real-time PCR methodology used to quantitate the biolocalization of adoptively transferred cells from EGFP-transgenic mice. The EGFP transgene copy number in the genome of many transgenic mouse strains is unknown. Transgenic mice often have tandem transgene copies at one insertion site (24) . Our laboratory was interested in understanding how the detected EGFP copy number related to the number of transgenic cells after adoptive transfer experiments.
RESULTS AND DISCUSSION
EGFP Transgene Copy Number in Transgenic Mice
The pEGFP-N3 plasmid was used to construct a standard curve; Taqman qPCR reproducibly detected as few as two EGFP transgene copies ( Figure  1B ). This standard curve was used to calculate the EGFP transgene copy number in 100 ng DNA isolated from lungs and livers of EGFP-transgenic mice. Replicates were consistent and EGFP C T values and copy number determinations did not differ significantly between lung and liver samples (See Table 1 for data from hemizygous Act-EGFP mice). C T values of the β-actin β-actin β housekeeping control were also consistent (23.42 ± 0.14 in these experiments) and were used to verify the template DNA concentration and integrity. No EGFP amplification was observed with DNA from tissue of C57BL/6 wild-type mice (negative controls) included in each assay.
Average transgene copy number results for Act-EGFP as well as Ubq-EGFP mouse strains are plotted in Figure 1C . The two copies of the EGFP transgene per diploid cell of hemizygous Act-EGFP mice are located in tandem, since the EGFP transgene is inserted at a single site in the genome of Act-EGFP mice (http:// kumikae01.gen-info.osaka-u.ac.jp/tg/ TGFISHresult1.cfm). The homozygous Ubq-EGFP mice contained a single transgene at a single insertion site per haploid cell and two copies per diploid (somatic) cell.
The control, both strains contained the same number of copies of the transgene (data not shown), consistent with our findings using a standard curve. We also found that homozygous Act-EGFP mice contained twice as many copies per diploid cell, as expected. Although others have used the Southern blot technique for determining transgene copy number, it is more tedious and time-consuming than qPCR and requires larger amounts of DNA.
One report compared Taqman-based qPCR to Southern blot techniques and concluded that the two methods gave similar results for low (<10) transgene copy numbers (25) .
Fluorescent Microscopic Evaluation of EGFP-VEC Localizing to Tissue Metastases
Previous studies using fluorescent microscopy demonstrated that intravenously administered fluorescent VEC localized to tissue metastases but were not detected in healthy organs. However, high tissue autofluorescence often prohibited the analysis of specimens, particularly lung tissue. For the current assay development study, groups of control mice and metastasisbearing mice were treated as described in Methods under Intravenous EGFP-VEC Injection (Figure 2A ). EGFP-VEC were manually enumerated by examining 10 μm liver sections by fluorescence microscopy (an average of 21 sections examined per group). No EGFP-VEC were found in liver sections from control groups 1 and 2 (healthy and metastases-bearing mice not injected with EGFP-VEC). A few apparent EGFP-VEC were detected in liver sections from a single mouse in control group 3 (healthy mice injected with EGFP-VEC). In contrast, a significant number of EGFP-VEC were detected in the tumor-bearing mice injected with EGFP-VEC (33 ± 7 EGFP-VEC/mm 2 as compared to 3 ± 5 in controls, P < 0.001, data not shown).
Fluorescent microscopy is a timeconsuming and subjective method for enumeration of tissue-localized cells. Imaging cytometric software was unsuccessful for the standardization and automation of EGFP-VEC enumeration 
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Quantitative PCR Evaluation of EGFP-VEC Localizing to Metastases
In order to compare directly with manual enumeration, liver tissue was scraped from the same slides counted in Figure 2A and gDNA was extracted and analyzed by qPCR. Replicates within each assay were consistent (average C T standard deviation = 0.24). Transgene was undetected in livers from the control groups. In contrast, EGFP was detected in 100% (4/4) of metastatic liver tissue from mice injected with EGFP-VEC. A Pearson correlation coefficient of 0.81 indicated a strongly positive correlation between the two methods (26) , although the actual number of EGFP-VEC per section differed ( Figure 2B ). Quantitative differences were most likely due to underestimation by PCR because of poor DNA recovery from the slides (170 ng/section) and because pooling sections diluted the transgene signal.
The qPCR assay with a detection limit of one cell in 100 ng DNA was sufficiently sensitive for in vivo studies provided that the ratio of transgenic to wild-type cell was consistently high throughout the sample. With heterogeneous tissue and with inconsistent localization patterns, as in our metastatic model, our current approach is to screen tissue sections at different levels for localized EGFP cells using microscopy and to assay the appropriate intervening sections by qPCR. Sensitivity could theoretically be improved with laser-capture microdissection (LCM); however, in our hands it has not been possible for us to sufficiently discriminate EGFP cells from background autofluorescence at high magnification. Successful LCM in this system requires additional immunohistochemistry with anti-EGFP antibodies.
Validation of qPCR Using Intratumor-injected Subcutaneous Tumors
Due to the low number of tumorlocalized VEC in the former experiment, we turned to an intratumor injection model for further assay validation. Alternating 10 μm s.c. tumor sections were analyzed by fluorescence microscopy and qPCR as described above. All of the tumors from eight EGFP-VEC-injected mice contained bright green EGFP-VEC by both microscopy and qPCR. qPCR quantitation again correlated with enumeration by manual cell count, both when assayed sections from all tumors were plotted (positive Pearson correlation of 0.61; Figure 3A ) and when average EGFP-VEC per section per mouse were compared (strongly positive Pearson correlation of 0.82; Figure 3B ). Although 85% of sections from saline-injected tumors showed bright green apparent cell-like structures by microscopy, no EGFP amplification was detected by qPCR in any saline control sample assayed, as expected. This was also true in some sections from EGFP-VECinjected tumors.
In order to distinguish fluorescent cells from microscopic artifacts, s.c. tumor sections were further analyzed using confocal microscopy. The fluorescence intensity of four 100 μm 2 areas per tumor, each containing an apparent fluorescent cell, was measured at each 1 μm optical z-stack plane ( Figure 3C ). Blinded analysis showed that the average mean and maximum fluorescence intensities of cell-like structures was significantly higher (P < 0.005) at all optical planes for EGFP-VEC-injected tumors compared with saline-injected tumors (wild-type tissue only). Confocal results supported the qPCR data, which only detected the EGFP transgene in VEC-injected tumors.
Fluorescent signals apparent by conventional microscopy were thus often due to tissue artifacts, not EGFP-VEC, leading to false-positive results. Autofluorescence is a welldescribed characteristic of mammalian tissue that confounds many GFP-based microscopic analyses. Autofluorescence is especially high in metabolically active tissue, such as liver and tumor (27) .
Short Technical Reports
In our studies, autofluorescence has precluded the accurate visual enumeration of fluorescent cells after adoptive transfer in tumor, lung, and liver tissues. Autofluorescence artifact is likely to account for inconsistent findings both within and between laboratories in studies of this nature, as has been suggested with stem cell engraftment studies (28) .
In contrast, the Taqman qPCR method is not prone to false positives; we have never observed a positive PCR signal in the absence of visualized cells. The accuracy of the PCR method is primarily limited by the detection limit (ratio of transgenic to wild-type cell or signal to noise) and DNA recovery. The qPCR assay for the EGFP transgene described here enables the more specific, rapid, and objective quantitation of biolocalized transgenic cells compared with the microscopic examination of histological specimens for cell transplantation studies. This assay can be readily extended to a wide array of in vivo experiments, to analyze the contribution of transplanted cells in regenerative medicine, cell-based immunotherapy, and pathogenesis.
